Pharming the field: PMPs raising interest, controversy
A growing interest in plant-made pharmaceuticals (PMPs), where crop plants become “factories” that manufacture therapeutic proteins extracted and used as the active pharmaceutical ingredient (API) in many medicines, is generating a new round of enthusiasm-and controversy.
New transistor technology could rearrange semiconductor cleanrooms
A recent announcement from SEMATECH (www.sematech.org) about what are known as mid-bandgap transistors may mean looming contamination-control challenges for semiconductor cleanrooms.
Cleanroom research focuses on next-gen wafer lithography
A 2,600-square-foot cleanroom, previously occupied by Infineon, is the new site of research and development of emerging wafer-lithography technologies being conducted by Fraunhofer Center for Nanoelectronic Technologies.
Wyeth opens mega biotech facility
Wyeth’s (www.wyeth.com) new 1.2-million-square-foot campus in Dublin, Ireland, believed to be one of the world’s largest biotechnology production facilities, is poised to produce advanced pharmaceutical technologies ranging from arthritis treatments to an antibiotic to fight serious skin and intra-abdominal hospital-acquired infections.
FDA issues rules on purity of therapeutics, food supply
The Food and Drug Administration (www.fda.gov) has proposed a rule for cGMPs of radioactive drug treatments, and has issued a final rule on safeguarding food packaging as a deterrent to bioterrorism.
Crawford steps down at FDA, Hussain reportedly moving on
After only a two-month stint as commissioner of the Food and Drug Administration (www.fda.gov), Lester M. Crawford submitted his resignation on Sept. 23, reportedly via an internal e-mail to FDA staff.